Recruiting
Phase 1
Phase 2

Behavioral Economic Intervention

Sponsor:

Rush University Medical Center

Code:

NCT07282418

Conditions

Cardiometabolic Health Indicators

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Recreation Enhancement

Study Details

Brief summary:

Risk for developing and dying from heart disease, type 2 diabetes, stroke, and other cardiometabolic conditions is strongly influenced by behavioral risk factors, including poor diet, physical inactivity, and tobacco and alcohol abuse. Behavioral economic models predict engagement in these behaviors as a function of their subjective value, ability to provide immediate gratification, and availability of competing alternatives. A key implication of the behavioral economic model is that increasing the accessibility of compelling alternative sources of reinforcement may displace engagement in unhealthy behaviors. Developing interventions that leverage these insights requires both a clear understanding of the characteristics of the "reward landscape" of U.S. adults, and the impact of altering the reward landscape on behavioral economic processes and health behavior.

This pilot study uses a trial within a cohort (TwiC) design to pursue these objectives. A representative sample of adults (N=120) will be enrolled into an observational cohort. Cardiometabolic health will be assessed and quantified based on the Life's Essential 8 (LE8) scoring system,4 which includes 4 behavioral (physical activity, diet quality, sleep, tobacco use) and 4 biomedical (non-HDL cholesterol, glucose, weight status, and blood pressure) factors. Structured home audit tools and an ecological momentary assessment (EMA) protocol will be used to measure environmental access to, demand for, and engagement in various rewarding activities, including different categories of recreational activity, electronic entertainment, social activities, and consumable rewards including food, tobacco products, and alcohol. The inter-relationships between different types of rewarding behaviors as substitutes or complements, and their links with cardiometabolic health, will be examined overall and with stratification by socioeconomic status.

Following completion of the first assessment, a subset of participants will be selected for randomization to a recreation-focused intervention or continued observation within the cohort based on their baseline status and protocol adherence. In TwiC designs, the "control" group simply continues to complete observational assessments within the cohort and is not notified that an intervention is ongoing. The BEAR "intervention" group will be approached for consent to participate in a 6-month behavioral economic intervention in which recreational activities are promoted as a strategy to displace cardiometabolic risk behaviors. The scientific aims of the randomized trial component of the study include examining change in LE8 scores, demand for various rewarding activities, discounting rates, and health behaviors. BEAR will also address several feasibility aims, including demonstrating the ability to measure and categorize access to rewarding activities, document recreation-related expenditures by participants, and estimate intervention uptake and acceptability.

Conditions

Cardiometabolic Health Indicators

Study ID

NCT07282418

Start date

May 11, 2026

Status verified date

Jun, 2026

Completion date

Jun 30, 2027

Anticipated

Primary completion date

Jun 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Eligibility criteria for BEAR main cohort enrollment (N=120):

  • Age 18 years or older
  • Fluent in English
  • Lives within 10 miles of the study site
  • Not planning to move outside the study region in the next 6 months
  • Has a working Android or iOS mobile device they are willing to use for EMA surveys and communication with the study team
  • No apparent cognitive deficits that would suggest a lack of capacity to consent or complete study procedures
  • No uncontrolled serious mental illness, marked by an inpatient hospitalization, increase or change in antipsychotic or mood stabilizing medication, or suicidal intent in the past 6 months.

Eligibility for selection into the RCT component (n=60):

  • At least 75% adherence to EMA surveys during the initial assessment
  • Complete baseline data within the observational cohort component
  • Participant endorses engagement in recreation less than 4 times per week based on EMA surveys
  • LE8 score <70, reflecting low to moderate cardiometabolic health.
  • No serious substance abuse problem based on an ASSIST score of ≥27 for any substance other than tobacco or cannabis
  • Willing and able to try recreational activities for the next 6 months

Study Design

Enrollment

120 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

no intervention: Continued observation

Participants in the Continued Observation arm will undergo regular assessment visits as part of the larger observational cohort study.

experimental: Recreation Enhancement

Participants in the Recreation Enhancement arm will be supported in identifying and engaging in recreational activities that may displace cardiometabolic risk behaviors.

Interventions

Recreation Enhancement

Recreation Enhancement includes coaching and financial support focused on engaging in recreational activities that may displace cardiometabolic risk behaviors.

Primary outcome measure

  • Life's Essential 8 score [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Bradley Appelhans, PhD

312-942-3477EatingLab@rush.edu

Locations

Rush University Medical Center

Recruiting

Chicago, Illinois, United States, 60612

Contacts

Michele Li, MS, RD

312-942-8260

More Information

Sponsor

Rush University Medical Center

Last update posted

Jun 18, 2026

Last verified

Jun, 2026

Keywords

  • recreation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Rush University Medical Center on 2026-06-18.